Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP) [Phase 2]
Phase 2 trial evaluating eltrombopag targeting the Bcl-xL pathway in idiopathic thrombocytopenic purpura (immune thrombocytopenia) completed…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura [Phase 3]
Phase 3 trial evaluating long-term dosing safety and efficacy of romiplostim in pediatric patients with immune thrombocytopenia purpura (ITP…
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of R935788 for persistent or chronic immune thrombocytopenia has completed with results pos…
-
FDA approval · 2018-12-14FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
The FDA approved Amgen's supplemental application for NPLATE (romiplostim), approving changes included in the submission (such as updates to…
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: H. Pylori Eradication for Moderate ITP [Phase 3]
Phase 3 trial investigating Helicobacter pylori eradication for immune thrombocytopenic purpura (ITP).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating low-dose decitabine for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP [Phase 3]
Phase 3 trial comparing decitabine plus dexamethasone versus dexamethasone alone for management of immune thrombocytopenia, status not repor…
-
CLINICAL_TRIALS withdrawal · 2018-08-14Clinical Trial Update: Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia [Phase 3]
Phase 3 clinical trial of rituximab and dexamethasone followed by mycophenolate mofetil or placebo in immune thrombocytopenia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-17Clinical Trial Update: End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
The EXTEND trial for Immune Thrombocytopenia has terminated and the medication is being discontinued for participants.
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) [Phase 2]
A Phase 2 trial evaluating eltrombopag for immune thrombocytopenia occurring in patients with chronic lymphoproliferative disorders has comp…
-
CLINICAL_TRIALS research · 2018-07-16Clinical Trial Update: A Chart Review of Rituximab Plus Repeated Cycles of Dexamethasone
This clinical trial update describes a chart review of Rituximab plus repeated cycles of dexamethasone in immune thrombocytopenia. The study…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia [Phase 4]
A Phase 4 trial update reporting completion of a study evaluating repositioning a second-line therapy for chronic immune thrombocytopenia.
-
FDA approval · 2018-04-17FDA Approved: TAVALISSE — Original Application (Rigel Pharmaceuticals, Inc.)
FDA approved TAVALISSE (fostamatinib) via an original application for adults with chronic immune thrombocytopenia.
-
CLINICAL_TRIALS research · 2018-04-10Clinical Trial Update: Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia [Phase 3]
Phase 3 clinical trial evaluating recombinant human thrombopoietin (rhTPO) for immune thrombocytopenia during pregnancy; status is unknown.
-
CLINICAL_TRIALS research · 2018-03-20Clinical Trial Update: Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
This clinical trial update describes an immune-genetic assessment study in immune thrombocytopenia (ITP); the current status is unknown.
-
CLINICAL_TRIALS research · 2018-03-15Clinical Trial Update: Study of Immune Thrombocytopenia Pathogenesis:
A trial investigating the pathogenesis of immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 1, Phase 2]
This document discusses a Phase 1/Phase 2 clinical trial evaluating a three-drug combination (atorvastatin, acetylcysteine, and danazol) for…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Rituximab Combining Bortezomib Versus Rituximab in Management of ITP [Phase 3]
A Phase 3 trial evaluating rituximab combined with bortezomib versus rituximab alone for immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura) [Phase 3]
A Phase 3 randomized trial comparing oral E5501 to eltrombopag in adults with chronic immune thrombocytopenia (Idiopathic Thrombocytopenic P…
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02) [Phase 3]
Phase 3 trial update on the efficacy and safety of oral E5501 plus standard of care for adults with chronic immune thrombocytopenia; study c…
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 2]
This is a Phase 2 trial evaluating daily AKR-501 tablets for 28 days in patients with chronic immune thrombocytopenia; the study has complet…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects [Phase 1]
A Phase 1 study assessing the drug-drug interaction between eltrombopag and cyclosporine in healthy subjects has completed.
-
CLINICAL_TRIALS research · 2017-10-27Clinical Trial Update: Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China
A clinical trial update evaluating health-related quality of life in adults with immune thrombocytopenia in China; no drugs or results are s…
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP) [NA]
A completed clinical trial from Assistance Publique – Hôpitaux de Paris investigating polymorphism and auto-reactive B and T cell subsets in…
-
CLINICAL_TRIALS research · 2017-10-19Clinical Trial Update: Immune Thrombocytopenia in Pregnancy
An ongoing clinical trial led by Assistance Publique - Hôpitaux de Paris investigates management of immune thrombocytopenia in pregnancy; th…